Polyrizon (NASDAQ:PLRZ) Announces Earnings Results

Polyrizon (NASDAQ:PLRZ) issued its earnings results on Wednesday. The company reported $2.81 earnings per share (EPS) for the quarter, FiscalAI reports.

Polyrizon Trading Up 4.8%

Shares of NASDAQ:PLRZ traded up $0.65 during midday trading on Wednesday, reaching $14.23. 23,009 shares of the company’s stock traded hands, compared to its average volume of 86,624. Polyrizon has a one year low of $2.88 and a one year high of $2,235.00. The stock has a 50 day moving average of $13.95 and a 200 day moving average of $9.73.

Hedge Funds Weigh In On Polyrizon

A hedge fund recently bought a new stake in Polyrizon stock. Jane Street Group LLC purchased a new position in Polyrizon Ltd. (NASDAQ:PLRZ) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned about 1.35% of Polyrizon at the end of the most recent reporting period.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Polyrizon in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.